Find policies, billing codes, payers, states, and providers
CPT 95024: Allergy Skin Testing with Interpretation and Report
CPT code 95024 covers skin testing for immediate allergic reactions with interpretation and a written report specifying the number of tests. As a common diagnostic procedure in allergy and immunology practice, it supports clinical decision-making for allergic rhinitis, conjunctivitis, chronic rhinosinusitis, and other suspected IgE-mediated conditions. Nationally, accurate coding of this service affects clinical documentation, quality measurement, and reimbursement flows across outpatient specialty care.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, United Healthcare, and Medicare. The publication provides a concise reference for clinicians, billing staff, and policy analysts on how CPT code 95024 fits into practice workflows and claims processing.
Readers will find: a clear explanation of the clinical service represented by the code; payer coverage context and common modifiers used in billing; typical sites of service and applicable specialty taxonomies; and related CPT codes that distinguish between percutaneous and intracutaneous testing approaches. The content emphasizes national applicability and operational considerations for documenting and reporting immediate-type allergy skin testing with interpretation and reporting.
Customize your policy alerts
Sign up for cpt 95024 policy alerts
Get alerted when payer policies referencing 95024 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 95024 describes the introduction of allergenic extracts into the skin to determine an immediate allergic response, followed by interpretation of results and a written report specifying the number of tests. This service is an in vivo allergy skin testing procedure that assesses immediate hypersensitivity reactions to specific allergens.
Service Type: Allergy skin testing with interpretation and report
Typical Site of Service: Outpatient clinic or office-based allergy/immunology setting, including specialist practices where skin testing equipment and staffed observation for immediate reactions are available.
National Reimbursement Benchmarks
National averages show notable separation: Medicare’s mean of $8 versus BUCA’s mean commercial of $48.4 highlights that commercial payers on average reimburse substantially more than the federal program for CPT 95024. Blue Cross Blue Shield and Aetna have higher mean values closer to the commercial side, while Cigna and UnitedHealth Group sit nearer to Medicare’s level. Dispersion varies across payers. Aetna displays the widest interquartile spread (P75–P25 = $94.0–$7.0 = $87.0), indicating greater variability in allowed rates, while Blue Cross Blue Shield is comparatively tight (P75–P25 = $75.4–$46.8 = $28.6). UnitedHealth Group shows moderate spread ($12.8–$2.9 = $9.9), and Cigna’s spread is relatively small ($10.8–$1.4 = $9.4). BUCA’s interquartile span ($60.1–$28.4 = $31.7) is closer to commercial variability than to Medicare’s very narrow quartiles (P75–P25 = $8–$7 = $1).